Inventor
WARD DONNA T
US18 patents
⚠️ This page may combine multiple inventors who share the name “WARD DONNA T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ISIS PHARMACEUTICALS INC
14 patentsUS7217572B2May 15, 2007
Modulation of HIF1α and HIF2α expression
ISIS PHARMACEUTICALS INC139 citations99
US7144999B2Dec 5, 2006
Modulation of hypoxia-inducible factor 1 alpha expression
ISIS PHARMACEUTICALS INC115 citations99
US6287860B1Sep 11, 2001
Antisense inhibition of MEKK2 expression
ISIS PHARMACEUTICALS INC334 citations98
US6448080B1Sep 10, 2002
Antisense modulation of WRN expression
ISIS PHARMACEUTICALS INC21 citations92
US6168950B1Jan 2, 2001
Antisense modulation of MEKK1 expression
ISIS PHARMACEUTICALS INC19 citations92
US6426221B1Jul 30, 2002
Antisense modulation of RIP2 expression
ISIS PHARMACEUTICALS INC8 citations74
US6165728ADec 26, 2000
Antisense modulation of NCK-2 expression
ISIS PHARMACEUTICALS INC8 citations74
US6165790ADec 26, 2000
Antisense modulation of PI3 kinase p55 gamma expression
ISIS PHARMACEUTICALS INC10 citations72
US7709453B2May 4, 2010
Modulation of the RNA interference pathway
ISIS PHARMACEUTICALS INC2 citations62
US7427470B2Sep 23, 2008
Antisense modulation of helicase-moi expression
ISIS PHARMACEUTICALS INC2 citations62
US6444466B1Sep 3, 2002
Antisense modulation of helicase-moi expression
ISIS PHARMACEUTICALS INC4 citations62
US6436706B1Aug 20, 2002
Antisense inhibitor of RECQL4 expression
ISIS PHARMACEUTICALS INC2 citations62
US6399378B1Jun 4, 2002
Antisense modulation of RECQL2 expression
ISIS PHARMACEUTICALS INC3 citations62
US6010906AJan 4, 2000
Antisense modulation of Jun N-terminal kinase kinase-1 expression
ISIS PHARMACEUTICALS INC0 citations52